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Abstract—We consider the use of intelligent systems to address
the long-standing medical problem of diagnostic differentiation
between harmful (secondary) and benign (primary) headache
conditions. In secondary headaches, the condition is caused by an
underlying pathology, in contrast to primary headaches where the
production of pain represents the sole constituent of the disorder.
Conventional diagnostic paradigms carry an unacceptable risk
of misdiagnosis, leaving patients open to potentially catastrophic
consequences. Intelligent systems approaches, grounded in arti-
ficial intelligence, are adopted in this study as a potential means
to unite contributions from multiple settings, including medicine,
the life sciences, pervasive computation, sensor technologies, and
autonomous intelligent agency, in the fight against headache
uncertainty. In this paper, we therefore present the first steps
in our research towards a data intensive, unified approach to
headache dichotomisation. We begin by presenting a background
to headache and its classification, followed by analysis of the
space of confounding symptoms, in addition to the problem
of primary and secondary condition discrimination. Finally, we
proceed to report results of a preliminary case study, in which the
epileptic seizure is considered as a manifestation of a headache
generating neuropathology. It was found that our classification
approach, based on supervised machine learning, represents a
promising direction, with a best area under curve test outcome
of 0.915. We conclude that intelligent systems, in conjunction
with biosignals, could be suitable for classification of a more
general set of pathologies, while facilitating the medicalisation of
arbitrary settings.
I. INTRODUCTION
Forms of head pain have troubled human populations as
far into the past as the historical record extends [1]–[6].
Today, known by the medical name Cephalalgia, headache
is defined as pain occurring anywhere in the region of the
head or the neck [7], representing a range of conditions that
cast a considerable burden on societies and individuals [8]–
[11]. It is estimated that around 50% of the global population
are directly affected by headache, with an economic impact
of £600 million per annum in the UK and between $5.6
and $17.2 billion in the US [12]. A broad distinction is
drawn between very common benign (primary) headaches
and relatively rare, potentially serious (secondary) types of
headache, resulting from underlying pathologies. A formidable
and enduring challenge within today’s healthcare setting is to
determine which cases represent conditions that are painful
and possibly debilitating, yet benign, and those which pose a
serious threat to patient health due to an underlying pathology.
Despite significant advances in both sciences relating to living
systems and in medical technologies, established procedures
for headache diagnosis remain complex and error prone, ex-
hibiting significant inter-observer variability, and often leaving
patients with considerable anxiety. Consequently, the risk
of misdiagnosis within populations remains moderate, with
potentially catastrophic consequences for individual patients.
The head itself constitutes a particularly essential anatomical
component of the human system, home to key functionality
centers, such as the sensory modalities of sight, hearing,
smell, and taste, and not least our centre of our conscious-
ness, personhood, and vital regulatory function, the brain.
Unsurprisingly, disruption to such an intricate and highly
sensitive structure can lead to immediate and irreversible
consequences to the health of individuals, especially where
loss of brain function occurs [13]. However, formations of
symptoms that may indicate the presence of serious problems
are confounded by a space of very common benign headache
types, known as primary headaches, for instance tension type
headache, migraine, cluster headache, that exhibit a significant
range of symptom expressions, overlapping in semblance
with the more serious conditions. The high prevalence of
primary headache within populations renders it impractical
within current healthcare frameworks to bring economically
costly diagnostic practices to each individual headache patient;
instead an emphasis is placed on clinical examination to select
cases only where deviations from known benign headache
prototypes are deemed evident. In this research, we report
on the potential and challenges of transforming the healthcare
posture for headache diagnostics through the use of intelligent
systems pathways that may disrupt existing practices. In
particular, we focus on the proposition that mass data from
physiological signals can be harnessed through the use of
artificial intelligence techniques to shift both the accuracy and
availability of diagnostics means, in addition to furthering
the capacity to observe and characterise headache causing
conditions. The rest of this paper is therefore organised as
follows. In Section II we review the background to headache
classification, following by Section III in which the space of
conflicting headache symptoms is considered. In Section IV
we discuss the characterisation of headache discrimination,
following which we report our progress towards empirical
analysis, in the form of a case study focusing on the classi-
fication of eplileptiform events, located in Section V. Finally,
we complete the paper in Section VI, in which conclusions
and future work are presented.
II. BACKGROUND TO HEADACHE CLASSIFICATION
The International Classification of Headache Disorders
(ICHD) specification represents the globally accepted standard
in headache classification, regarded by both researchers and
medical practitioners as the leading authority. The introduction
of this model by the International Headache Society (IHS),
beginning in 1998, has served to rationalise the diagnosis and
treatment of headaches, providing a standard set of terminol-
ogy and operational diagnostic criteria that has contributed
significantly to the accuracy and consistency of headache di-
agnosis and treatment [14]. The World Health Organisation has
recognised the ICHD headache classification, incorporating
criteria into the International Classification of Diseases 10
(ICD 10) definition [15]. The progression of ICHD models, in
order of succession, comprises editions ICHD-I (1988) [16],
ICHD-II (2004) [17], still in wide use, and more recently
ICHD-III-beta (2013) [18]. The ICHD-II model provides an
evidence based update to the ICHD-I, which is based mainly
on expert opinion. The ICHD model editions were preceded
by earlier attempts to classify headaches, with works including
Brown in 1951 [19], followed by an Ad-hoc model by intro-
duced by the US organisation the National Institute of Health
(NIH) in 1962 [20]. Early models, however, did not encompass
the full range of headaches and did not gain wide acceptance.
The modern era of headache classification is further preceded
by historical interpretations [21], including work by Christian
Baur in 1787, in which a total of 84 categories are described
and broadly divided into “idiopathic” and “symptomatic”,
reflecting the notion of primary and secondary headaches,
in addition to the work of Thomas Willis, recognised as a
founder of modern neurological thought [22]. The depth of
history surrounding headache conditions highlights both the
enduring and elusive nature of the phenomenon, for which
further review can be found in [23]–[25].
III. THE SPACE OF CONFLICTING SYMPTOMS
Owing to the complexity of the human biological system,
within which a wide range of potential disorders may cor-
respondingly (co)exist, manifestations of differing headache
disorders have the flexibility to strongly resemble one another,
especially at the level of clinical symptoms. A danger therefore
exists that a serious underlying condition may be mistaken for
a benign primary headache, with potentially critical conse-
quences for the patient. This phenomenon of “false friends” in
the presentation space has been acknowledged in the literature,
where the constellation of reports collectively highlights the
complex nature of accurately linking clinical symptoms and
signs to true underlying conditions. Sentinel headache (SH),
as reported in [26], [27], is an early warning sign of the more
serious Subarachnoid Haemorrhage (SAH), of which milder
presentations are possible that may resemble primary headache
types in terms of clinical features. Transient Ischemic attacks
are another significant form of intracranial aetiology, where
a subspace of presentations that resemble migrainous features
are possible [28]. Cardiac Cephalgia may also be misdiagosed
as migraine, as reported in [29], in addition to cerebellar
infarction [30].
An abnormality of intracranial pressure is a further sig-
nificant aetiology in patients, reported in [31] to mimic the
features of cluster headache in the case of idiopathic intracra-
nial hypertension. Furthermore, following mild head injury,
acute post-traumatic headache may clinically resemble a range
of primary headache types, including Migraine, Probable
migraine, Tension type headache (TTH), Probable TTH, or
unclassified primary headache [32]. Additional intracranial
pathologies add to the list of primary headache mimics, in-
cluding confounding aspecific headaches [33]. The epilepsies
are also a group of disorders that may give rise to presentations
that resemble primary headaches. Occipital lobe epilepsy for
example is known in certain forms to exhibit symptoms that
may be misdiagnosed as migraine [34]–[36]. Non-epileptic
neurodisorders can also trigger a misdiagnosis of migraine
due to coinciding patterns of symptoms, for instance Huete et
al report on Hashimoto’s encephalopathy in [37]. Secondary
headaches driven by cervical and ocular pathologies give rise
to additional symptom groups that reflect primary headache
prototypes such as migrain and TTH, examples of such scenar-
ios include cervical spine pathologies [38], [39] and subacute
angle-closure glaucoma [40], [41]. Toxicological effects must
also be considered as a source of various headache symptoms,
for example carbon monoxide poisoning is known to resemble
migrainous symptoms as reported in [42]. Further unspecified
pathologies are likely to exist in addition to those covered here,
continuing the spectrum of serious disorders that may appear
benign.
IV. THE PROBLEM OF SECONDARY HEADACHE
DISCRIMINATION
The problem of secondary headache diagnosis does not
admit a well defined entry point or a single sufficient solution
element. The compact term “secondary headache” in fact
refers to any entity or subset within the space of all possible
diseases and disorders from which headache may consequently
result. The problem is therefore highly heterogeneous, rooted
in a large body of pathologies, and is resistant to the idea
of an overarching unifying principle. The symptoms of any
one inclusive disorder are often themselves heterogeneous,
sensitive to initial conditions, and may interrelate in com-
plex ways with further coexisting disorders. A key objective
for front line physicians, who represent the first point of
contact with presenting patients, is to answer the question,
“is there an underlying condition present in this patient?”.
Addressing this question is crucial, since more costly tests,
for example neuroimaging, cannot be applied a priori without
compromising the economic viability of the healthcare system
as a whole [43], [44]. Such a question should, in light of
emerging healthcare paradigms [45]–[47], be widened in
scope to include additional concerns, in particular the detection
of pre-symptomatic disorders and the extension of diagnostic
capacity to operate as a non-disruptive agency within the
course of patient lives.
V. INITIAL RESEARCH PROGRESS: EPILEPTIC SEIZURE
CLASSIFICATION
To begin our investigation into secondary headache analysis,
we present a case study through which we examine the
potential of machine learning for the analysis of biosignals
originating from the Electroencephalographam (EEG). In par-
ticular, we focus upon supervised classification, defined as
the ability to learn a functional mapping between a feature
space of arbitrary dimension and a set of discrete classes,
giving the form yˆ = fˆ(x), x ∈ Rn, yˆ ∈ {0, 1}. We set
as an initial objective the classification of seizure activity
in Epilepsy, a well documented condition that is known to
present in many cases with the symptoms of headache [48],
[49]. The epilepsies are a group of chronic, heterogeneous
neurological disorders, affecting an estimated 1% of the worlds
population [50], characterised by recurrent, intermittent, invol-
untary, paroxysmal seizure episodes [51]. The purpose of this
pilot study is to establish a proof of principle result, within
the parameters of our intelligent systems approach, so as to
demonstrate the viability to detect and potentially therefore
predict a headache generating condition. In similar scenarios,
it is widely documented that further headache producing
conditions, such as brain tumour aetiologies, may also often
lead to anomalies of neuronal activity that consequently affect
the EEG and neuroimaging recordings [52]. A natural next
phase in this research is therefore to apply the methodology
developed for this case study to a more general selection
of headache generating scenarios. As such, the methodology
used in this case study is designed to provide an initial basis
to suitably justify the continued exploration of the limits
and generalisability of biosignal analysis for the secondary
headache inquiry, using epilepsy as a first pilot example.
A. Scalp EEG Data Set
To empirically evaluate the effectiveness of our approach,
we make use of an open dataset of scalp EEG recordings
obtained from the Physionet project (listed as CHB-MIT) [53],
[54]. The data consists of the digitised EEG segments collected
from a total sample of 23 subjects, 22 of which were observed
at the Childrens Hospital in Boston, with a further subject
whose details are unknown. The known subjects range in
age from 1.5 to 22 years. All of the subjects under study,
who were admitted for refractory epilepsy, had anticonvulsant
medication withdrawn prior to monitoring, to facilitate the
observation of seizure events. During the recording process,
181 events occurred that were identified as clinical seizures, as
determined by expert opinion. The experts provided annotation
of the earliest and latest EEG state transitions associated with
each seizure event. The resulting annotations are adopted as
ground truth labels within this study. The output from the
EEG activity records is organised according to 24 cases (1
subject appears in two cases, recorded 1.5 years apart), where
each case reflects the observation of a single subject over
time. Within each case, the EEG output is distributed over a
number of consecutive files, each generally containing an hour
in duration of uninterrupted data. Time gaps exist at each file
boundary, most reportedly enduring for around 10 seconds. It
is stated that such interruptions were introduced at the time
of recording due to hardware limitations of the equipment in
use.
The EEG data were recorded according to the 10-20
international standard, with the exception of 17 files with
different montages. Consequently, the sensor space consists of
19 electrodes and 1 ground attached to the surface of the scalp,
resulting in simultaneous output from 23 spatially associated
channels via differential amplification, namely FP1-F7, F7-T7,
T7-P7, P7-O1, FP1-F3, F3-C3, C3-P3, P3-O1, FZ-CZ, CZ-PZ,
FP2-F4, F4-C4, C4-P4, P4-O2, FP2-F8, F8-T8, T8-P8, P8-O2,
P7-T7, T7FT9, FT9-FT10, FT10-T8, and T8-P8. Recording
equipment was used to sample channel output at a rate of 256
Hz, with 16 bit resolution, for all observations. Uninterrupted
file durations are generally 1 hour, with the exception of those
present in case 10 which are two hours in length, and those
of cases 4, 6, 7, 9, and 23, which endure for four hours each.
Present in the sample of subjects observed were 5 males, aged
between 3 and 22 years, and 17 females, aged between 1.5
and 19 years, in addition to an unknown subject assigned
to a single case. The captured data presents 141 record files
that contain at least one seizure and 545 record files with no
seizure activity, referred to as seizure and non-seizure files
respectively. Overall, a total of 982 hours of EEG recording
are represented across 686 edf record files, encompassing a
total of 181 clinical seizure events.
B. Feature Definitions
We use six feature in our study, as formally defined in
Table I. Each distinct feature serves to isolate a signal charac-
teristic of interest by substituting the full granularity of the
raw signal representation with a constrained computational
product. Such computed features represent an estimation of
the true properties of the underlying dynamical system, in
this case neuroelectric brain activity, where the closeness
of correspondence to the original system is bounded by the
duration, resolution, and quality of the time series measured
for such a system. Our feature set covers spectral characteristic
estimators, signal strength estimators, and statistical moments,
all of which are univariate measures. Peak frequency (PF) is
used to compute the frequency component of each signal that
satisfies the global maxima when viewed from the perspective
of the signals power spectral density (PSD). A related location
measure is the median frequency (MF), providing an estimate
of the typical signal frequency, while showing robustness
against outlying frequency components. Root Mean Square
(RMS) is also used in this study as a means to estimate
the strength of the signal over a given time domain interval.
The RMS provides a summary of the magnitude of the
signal. We consider next a signal strength estimator, the Signal
Energy (SE). SE measures the sum of the squared magnitude
of the samples taken over a given signal interval. Finally,
we consider the statistical moment estimators the Skew and
Kurtosis, defined respectively as measuring the symmetry and
peakedness of the varying amplitude of signal in the time
domain.
TABLE I: Feature Definitions
Index Feature Name Definition
1. PF Peak Frequency fmax = arg(
fs
n
maxN−1i=0 p(i))
2. MF Median Frequency fmed = im
fs
N
,
i=im∑
i=0
P (i) =
i=N−1∑
i=im
3. RMS Root Mean Square RMS =
√√√√ 1
N
N−1∑
i=0
x(i)2
4. E Signal Energy E =
N∑
k=1
X2k
5. SKW Skew s =
E(X − µ)3
σ3
6. KRT Kurtosis k =
E(X − µ)4
σ4
C. Performance Measurement
In order to evaluate the capability of our classifiers, we
introduce a framework of performance measures, which are
evaluated for each of the models tested. We used models
purposely chosen from different theoretical classes, to provide
points of reference in performance. We reason that to be
justified, our test classifiers should significantly outperform
both linear classes of models and also simplistic models
such as K-nearest neighbour (weak learners). Additionally,
to demonstrate that the data we used as input contains true
dependency, we compared the performance of all of the
models presented with a random guessing baseline, serving
as a calibration point, to show that uninformed decisions are
insufficient to produce significant results. Consequently, the
informed models are shown to synthesise patternful informa-
tion from the data. Additionally, since generalisation is the
goal of our classifier, we apply the described performance
framework to both the training (in-sample) and test (out-of-
sample) results. Such a comparison of results between the
training and test procedures provides an indication of any
overfitting that may have occurred during model parameter
optimisation, in addition to demonstrating the generalisation
capability of each classifier, through the correspondence of
both sets of results. To furnish the classifier responses with
objective measures of performance, we utilise both graphical
methods and scalar summaries, as listed in Table II.
TABLE II: Performance Metrics
Metric Abbr. Computation Range
Area Under Curve AUC 0 6 area(ROC) 6 1 [0,1]
Sensitivity SEN TP/(TP+FN) [0,1]
Specificity SPEC TN/(TN+FP) [0,1]
Precision PRE TP/(TP+FP) [0,1]
F1 Score F1 2·(PRE·RC)/(PRE+RC) [0,1]
Youden’s J Statistic J Sensitivity + Specificity - 1 [-1,1]
Accuracy ACC (TP+TN)/(TP+FN+TN+FP) [0,1]
TP = True Positive Count
TN = True Negative Count
PRE = Precision
RC = Recall
ROC = Receiver Operating Characteristic
D. Exploratory Analysis
Prior to the development and training of classifier models,
we considered visualisations of the dataset, such that the
structure could be approximated via a mapping into two
dimensional graphical form. Results are obtained for both Prin-
cipal Component Analysis (PCA) and t-Distributed Stochastic
Neighbourhood Embedding (t-SNE) [55] procedures, as shown
in Figures 2 and 3, respectively. Additionally, we viewed the
EEG montages to gain visual insight into the nature of the
signals, an EEG montage exemplar is shown in Figure 1. The
exploratory results indicate that the signals are complex and
exhibit no clear discrimination in the two dimensional setting,
especially in the PCA domain, justifying the classification
approach via machine learning procedures.
1) Overview of Main Experimental Setup: To evaluate the
capability of our proposed classifiers, we conducted a series
of empirical simulations, using the CHB-MIT EEG signal
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Fig. 2: Principal Component Analysis Plot
0 = no seizure, 1 = seizure
database as our sample. The models used in our experiment
are listed in Table III. We provide details of our analytical pa-
rameters in the sections immediately following, where aspects
of the procedural setup are organised into loosely orthogonal
concerns.
2) Feature Origination: Six features were extracted from
10 second discretised quasi-stationary segments of the original
time domain signals, using calculations as defined in Sec-
tion V-B. The feature calculations were applied to all 23 EEG
time domain channels, resulting in a total of 138 features for
each unit in the discretised time domain (later reduced using
PCA to 35 mapped features).
3) Data Holdout Procedure: The trials presented in this
work were conducted using a data set partitioning scheme,
reserving 70% of the data for model training and the remaining
30% as hold out for testing.
4) Simulation Setup: For the simulation of our models
we undertook a data loading phase, followed by a primary
model execution phase. Firstly, the prepared features matrix
was loaded and PCA applied to map the original feature set to
a lower dimensional space, by capturing the first 35 principal
components. The purpose of this initial mapping operation is
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Fig. 3: tSNE Plot
0 = no seizure, 1 = seizure
to improve the training example to feature ratio and also to
discard noise components, to promote better generalisation.
The models to be evaluated were simulated 30 times, following
which the means of results from individual trials for each
model were taken and used as a basis to derive performance
metrics.
5) Models and Trial Definitions: As shown in Table III, we
pose 11 models for evaluation. Each model was presented with
the set of features derived from EEG signal data, as described
in previous sections. Each trial in our experiment corresponds
to an entry listed in the table.
E. Results
The results from our experimental procedure are presented
and organised in the following listing, where classifier perfor-
mance is evaluated over the test holdout set from our data. Ta-
ble IV lists the results for each respective classifier, according
to the performance metrics we introduced previously. We then
proceed to present our evaluation of the classifiers according
to ROC curve analysis, where AUC and ROC curve plots are
considered. Figure 4 shows a bar plot for the AUC values for
each classifier, while Figure 5 presents the corresponding ROC
curves.
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Fig. 4: AUC Plots for the Test Set
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TABLE III: Models
No. Model Description Architecture Training Algorithm Role
1. ROM Random Oracle Model Pseudo-random Number
Generator
NA RAND
2. LNN Linear Neural Network 35 Units, Linear
Activations
Batch training with
weight and bias
learning rules
LB
3. KNN K-Nearest Neighbour 3 Neighbours Instance Induction WNLB
4. KNNS K-Nearest Neighbour
Stacked
Stacked KNN Stacked Instance
Induction
TC
5. SVM Support Vector Machine Matrix Kernel Quadratic
Optimisation
TC
6. RFC Random Forest
Classifier
Decision Tree Ensemble Random feature
subset bagging
TC
7. VPC Voted Perceptron
Classifier
2054 Perceptron
Ensembles
Delta Rule TC
8. LEVNN Levenberg Neural
Network
Units: 35-28-2 Levenberg-
Marquardt
TC
9. S1 Stacked Generaliser 1 4 LEVNN, with hidden
layer neurons: 2,5,10,20
Hybrid TC
10. S2 Stacked Generaliser 2 LEVNN 35-20-2,
LEVNN 35-10-2, VPC
35-20-2, VPC 35-30-2
Hybrid TC
11. S3 Stacked Generaliser 3 LEVNN 35-20-2, VPC
35-20-2, RFC
Hybrid TC
Key:
RAND = Random Baseline
LB = Linear Baseline
WNLB = Weak Non-linear Baseline
TC = Test Classifier
TABLE IV: Results (test holdout, seizure class)
Model Sensitivity Specificity Precision F1 J Accuracy AUC
ROM 0.548 0.467 0.412 0.47 0.0154 0.5 0.471
LNN 0.819 0.832 0.768 0.793 0.651 0.827 0.879
KNN 0.789 0.889 0.829 0.809 0.679 0.849 0.903
KNNS 0.837 0.828 0.768 0.801 0.665 0.832 0.915
SVM 0.843 0.861 0.805 0.824 0.704 0.854 0.902
RFC 0.705 0.803 0.709 0.707 0.508 0.763 0.783
VPC 0.861 0.82 0.765 0.81 0.681 0.837 0.908
LEVNN 0.849 0.828 0.77 0.808 0.677 0.837 0.897
S1 0.825 0.881 0.825 0.825 0.706 0.859 0.906
S2 0.843 0.836 0.778 0.809 0.679 0.839 0.91
S3 0.807 0.746 0.684 0.74 0.553 0.771 0.814
F. Discussion
Prior to consideration of the test classifiers, we first observe
through the results that the uninformed guessing model (ROM)
is unable to discriminate better than chance between the two
classes, providing a suitable benchmark against which the
significance of classifier performances can be gauged. Fur-
thermore, the establishment of the non-discriminative random
performance provides an indication that no systematic bias is
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Fig. 5: ROC Plots for the Test Set
0 = no seizure, 1 = seizure
present as a function of the data itself. Subsequently, evident
in the classifier results is the capability of the linear baseline,
the LNN, to achieve performance levels close to those of
the other informed models of non-linear expressive capacities.
For example, the LNN achieved an AUC of 0.902 for the
training set, and 0.879 for the testing set respectively, in
comparison to 0.911 and 0.897 for the LEVNN, a non-linear
model with universal approximation capability [56]. Nearly all
of the informed classifiers obtained AUC values near to 0.9
for the test set evaluation, with the exceptions of the RFC
and S3 models, which appear to have overfit the training
set. The KNNS classifier is also indicated for overfitting,
having achieved ideal results during training and dropping in
performance upon exposure to the test set. The increase in
expressive power added to the KNN base learners through
stacking has not improved the models capacity to synthesise
useful information. Overall, the S1 model appears to have
performed marginally better than the other models, though
performance over the informed models, with the exception
of RFC and S3, appears similar. The KNN, although having
achieved an AUC of 0.903 for the test set, has suffered a lower
sensitivity of 0.789, due to the geometry of the ROC curve;
it can be seen in Figure 5 that for the seizure class the curve
falls away from the maxma of the sensitivity axis (Y) to a
greater extent than from the minima of the false positive rate
axis (X), resulting in the observed bias towards specificity.
When considering the results from the perspective of rel-
ative standing, a lack of a clear separation in discriminative
performance between the non-linear classes of model versus
that of the LNN baseline is evident, extending also to less
complex non-linear models such as the KNN. The lack of
distinction between the non-linear versus the linear results
suggests that the current set of features may have failed
to adequately capture relevant non-linear components from
the original signal, since non-linear capacity appears to offer
very little advantage for the experimental trials conducted.
There are clearly, however, informative linear components
within the data, since all informed classifiers were able to
perform significantly beyond that of the ROM baseline. It is
possible that excessive granularity has been discarded form the
original EEG signals, indicating that further investigation of
the original signals may be of benefit to improve classification
performance outcomes. Additionally, it is also a possibility
that the current feature set may be closely coupled to variance
of the signal, rather than acquiring a deeper structure in
the signal, since seizure events tend towards greater signal
volatility. A further source of performance impairment may
be a remainder of artefacts and noise sources embedded
within the data, disrupting the discriminative capability of the
classifiers. We therefore recommend for future work relating
to this experiment that the space of features is further inter-
rogated and expanded, including examination of the discrete
time intervals over which the features are extracted, that a
surrogate approach is included to account for the proportion
of excess performance due to signal variance, and that further
preprocessing techniques and their implications are assessed
to improve the signal to noise ratio prior to the extraction of
features.
VI. CONCLUSION AND FUTURE WORK
In this work we have considered the enduring medical
problem of diagnostic differentiation between primary and
secondary forms of headache, the misdiagnosis of which may
result in immediate and irreversible consequences for the
patient. Both primary and secondary headache terms are seen
not to comprise a single entity, but in fact encompass a highly
complex, heterogeneous space of conditions, within which
symptoms relating to causes of markedly differing origins may
exhibit significant overlap. Costly specialist procedures such
as CT and MRI neuroimaging, while providing rich internal
views of the human biological system, do not represent a
sustainable, scalable means of diagnosis, since they can be
applied only in cases where a priori indication of a problem
exists. We therefore presented a strategy grounded in the
hypothesis that data intensive biosignals analysis, originating
from increasingly available sensor technologies, may be en-
abled through an intelligent systems methodology, giving rise
to a deepened scope of analysis with the necessary operational
features for use over arbitrary diagnostic junctures. Moreover,
we recognise that the complexity inherent in bio-domain
analysis in fact necessitates the extrication of low level human
input, since considerable complexity must be handled within a
restrictive time frame. The use of intelligent systems therefore
permits a level of utility normally provided through the work
of multidisciplinary teams, to be combined into a single
unit of operation, driven by a marginal resource footprint.
To demonstrate the potential of our proposed strategy, we
reported a preliminary experiment, in which the Epilepsies, a
group of paroxysmal neurological disorders, known to result in
headaches, were considered within the framework of a classi-
fication problem. Using supervised machine learning, the time
series of EEG signals were segmented and analysed, with the
resulting outcomes classified as either seizure or no-seizure. It
was shown that a maximum AUC of 0.915 was achieved by a
stacked KNN model (KNNS). Further results were consistent
with this finding, with models SVM, KNN, VPC, S1, and S2
achieving close to an AUC of 0.9. Generalising this approach
to further pathologies, we propose that the dichotomisation
of primary and headaches can be achieved through continued
development of the strategy presented.
In future work we intend to expand on our current progress
to identify and operationalise further points of difference
between primary headache scenarios and secondary headache
causing conditions, exploring also an expanded range of both
biosignals and analytical techniques with which to exploit
such discriminative opportunities. In particular, we aim to
test key pathological conditions such as subarachnoid haem-
orrhage, forms of brain tumour, infection, traumatic brain
injury conditions, raised intracranial pressure, in addition to
further seizure conditions. In terms of biosignals, we consider
the use of emerging intracranial biosignal modalities that
hold promise for portable solutions, such as microwave imag-
ing [57], magneto-acoustic imaging and detection (MAI) [58],
ultrasound methods such as Transcranial Doppler ultrasonog-
raphy (TCD) [59], and near infrared imaging (NIR) [60], in
addition to alternatives to EEG such as Magnetoencephalog-
raphy (MEG). Moreover, we consider the use of deep learning
algorithms to represent a key direction in analysis, allowing ar-
bitrarily complex signal combinations to be evaluated without
the bottleneck of feature hand engineering [61], [62].
REFERENCES
[1] R. Assina, C. E. Sarris, and A. Mammis, “The history of craniotomy for
headache treatment,” Neurosurgical focus, vol. 36, no. 4, p. E9, 2014.
[2] A. P. Friedman, “The headache in history, literature, and legend.”
Bulletin of the New York Academy of Medicine, vol. 48, no. 4, p. 661,
1972.
[3] L. Bayan, S. M. Modarres Mousavi, and A. Gorji, “History of neuro-
logical disorders in persian medicine,” Journal of Research on History
of Medicine, vol. 2, no. 4 Nov, 2013.
[4] A. Gorji and M. K. Ghadiri, “History of headache in medieval persian
medicine,” The Lancet Neurology, vol. 1, no. 8, pp. 510–515, 2002.
[5] M. J. Eadie, Headache: through the centuries. OUP USA, 2012.
[6] S. Collado-Va´zquez and J. Carrillo, “Cranial trepanation in the egyp-
tian,” Neurologı´a (English Edition), vol. 29, no. 7, pp. 433–440, 2014.
[7] J. La Jolla Donald et al., Wolff’s headache and other head pain. Oxford
University Press, 2001.
[8] P. Pop, C. Gierveld, H. Karis, and H. Tiedink, “Epidemiological aspects
of headache in a workplace setting and the impact on the economic
loss,” European Journal of Neurology, vol. 9, no. 2, pp. 171–174, 2002.
[9] B. K. Rasmussen, R. Jensen, M. Schroll, and J. Olesen, “Epidemiology
of headache in a general populationa prevalence study,” Journal of
clinical epidemiology, vol. 44, no. 11, pp. 1147–1157, 1991.
[10] L. J. Stovner, J.-A. Zwart, K. Hagen, G. Terwindt, and J. Pascual,
“Epidemiology of headache in europe,” European journal of neurology,
vol. 13, no. 4, pp. 333–345, 2006.
[11] L. Stovner, K. Hagen, R. Jensen, Z. Katsarava, R. Lipton, A. Scher,
T. Steiner, and J.-A. Zwart, “The global burden of headache: a documen-
tation of headache prevalence and disability worldwide,” Cephalalgia,
vol. 27, no. 3, pp. 193–210, 2007.
[12] C. Clarke, L. MacMillan, S. Sondhi, and N. Wells, “Economic and social
impact of migraine.” Qjm, vol. 89, no. 1, pp. 77–84, 1996.
[13] T. Wieloch and K. Nikolich, “Mechanisms of neural plasticity following
brain injury,” Current opinion in neurobiology, vol. 16, no. 3, pp. 258–
264, 2006.
[14] K. Ravishankar, “The ihsclassification (1988, 2004)–contributions, lim-
itations and suggestions,” J Assoc Physicians India, vol. 58, pp. 7–9,
2010.
[15] I. H. C. Committee et al., “Icd-10 guide for headaches,” Cephalalgia,
vol. 17, no. suppl 19, p. 32, 1997.
[16] H. C. C. of the International Headache Society et al., “Classification and
diagnostic criteria for headache disorders, cranial neuralgias and facial
pain,” Cephalalgia, vol. 8, pp. 1–96, 1988.
[17] J. Olesen and T. Steiner, “The international classification of headache
disorders, 2nd edn (icdh-ii),” Journal of Neurology, Neurosurgery &
Psychiatry, vol. 75, no. 6, pp. 808–811, 2004.
[18] H. C. C. of the International Headache Society (IHS et al., “The interna-
tional classification of headache disorders, (beta version),” Cephalalgia,
vol. 33, no. 9, pp. 629–808, 2013.
[19] M. R. Brown, “The classification and treatment of headache.” The
Medical clinics of North America, vol. 35, no. 5, pp. 1485–1493, 1951.
[20] A. P. Friedman, K. H. Finley, J. R. Graham, E. C. Kunkle, A. M. Ostfeld,
and H. G. Wolff, “A classification of headache ad hoc committee on
classification of headache,” Neurology, vol. 12, no. 5, pp. 378–378, 1962.
[21] M. Levin, Comprehensive review of headache medicine. Oxford
University Press, 2008.
[22] H. Isler, “Thomas willis’, two chapters on headache of 1672: A first
attempt to apply the new science to this topic,” Headache: The Journal
of Head and Face Pain, vol. 26, no. 2, pp. 95–98, 1986.
[23] ——, “Headache classification prior to the ad hoc criteria,” Cephalalgia,
vol. 13, no. 12, pp. 9–10, 1993.
[24] A´. L. Guerrero-Peral, V. de Frutos Gonza´lez, and M. I. Pedraza-Hueso,
“Galeata: chronic migraine independently considered in a medieval
headache classification,” The journal of headache and pain, vol. 15,
no. 1, p. 1, 2014.
[25] E. Magiorkinis, A. Diamantis, D.-D. Mitsikostas, and G. Androutsos,
“Headaches in antiquity and during the early scientific era,” Journal of
neurology, vol. 256, no. 8, pp. 1215–1220, 2009.
[26] F. De Falco, “Sentinel headache,” Neurological Sciences, vol. 25, no. 3,
pp. s215–s217, 2004.
[27] J. L. B. Pereira, L. A. F. de Albuquerque, M. Dellaretti, G. T. C.
de Carvalho, G. V. Junior, M. I. Rocha, L. L. A. Loures, P. P. Christo,
and A. A. de Sousa, “Importance of recognizing sentinel headache,”
Surgical neurology international, vol. 3, 2012.
[28] S. Prabhakaran, A. J. Silver, L. Warrior, B. McClenathan, and V. H. Lee,
“Misdiagnosis of transient ischemic attacks in the emergency room,”
Cerebrovascular Diseases, vol. 26, no. 6, pp. 630–635, 2008.
[29] Y. Torres-Yaghi, J. Salerian, and C. Dougherty, “Cardiac cephalgia,”
Current pain and headache reports, vol. 19, no. 4, pp. 1–5, 2015.
[30] S. I. Savitz, L. R. Caplan, and J. A. Edlow, “Pitfalls in the diagnosis
of cerebellar infarction,” Academic emergency medicine, vol. 14, no. 1,
pp. 63–68, 2007.
[31] M. Volcy and S. Tepper, “Cluster-like headache secondary to idiopathic
intracranial hypertension,” Cephalalgia, vol. 26, no. 7, pp. 883–886,
2006.
[32] D. Lieba-Samal, P. Platzer, S. Seidel, P. Klaschterka, A. Knopf, and
C. Wo¨ber, “Characteristics of acute posttraumatic headache following
mild head injury,” Cephalalgia, vol. 31, no. 16, pp. 1618–1626, 2011.
[33] E. Wouda and J. Vanneste, “Aspecific headache during 13 years as the
only symptom of idiopathic hypertrophic pachymeningitis,” Journal of
Neurology, Neurosurgery & Psychiatry, vol. 64, no. 3, pp. 408–409,
1998.
[34] M. Walker, S. Smith, S. Sisodiya, and S. Shorvon, “Case of simple
partial status epilepticus in occipital lobe epilepsy misdiagnosed as
migraine: clinical, electrophysiological, and magnetic resonance imaging
characteristics,” Epilepsia, vol. 36, no. 12, pp. 1233–1236, 1995.
[35] B. Menon, “Symptomatic occipital epilepsy misdiagnosed as migraine,”
Headache: The Journal of Head and Face Pain, vol. 47, no. 2, pp.
287–289, 2007.
[36] C. Panayiotopoulos, I. A. Sharoqi, and A. Agathonikou, “Occipital
seizures imitating migraine aura,” Journal of the Royal Society of
Medicine, vol. 90, no. 5, pp. 255–257, 1997.
[37] A. J. Huete, M. Sanchez-del Rio, and O. Franch, “Hashimoto’s en-
cephalopathy mimicking migraine with aura,” Headache: The Journal
of Head and Face Pain, vol. 47, no. 1, pp. 130–131, 2007.
[38] W. Po¨llmann, M. Keidel, and V. Pfaffenrath, “Headache and the cervical
spine: a critical review,” Cephalalgia, vol. 17, no. 8, pp. 801–816, 1997.
[39] X. Yi, A. J. Cook, R. J. Hamill-Ruth, and J. C. Rowlingson, “Cervico-
genic headache in patients with presumed migraine: missed diagnosis or
misdiagnosis?” The Journal of Pain, vol. 6, no. 10, pp. 700–703, 2005.
[40] K. S. Shindler, P. S. Sankar, N. J. Volpe, and J. R. Piltz-Seymour,
“Intermittent headaches as the presenting sign of subacute angle-closure
glaucoma,” Neurology, vol. 65, no. 5, pp. 757–758, 2005.
[41] D. I. Friedman, L. K. Gordon, and P. A. Quiros, “Headache attributable
to disorders of the eye,” Current pain and headache reports, vol. 14,
no. 1, pp. 62–72, 2010.
[42] M. Eberhardt, A. Powell, G. Bonfante, V. Rupp, J. R. Guarnaccia,
M. Heller, and J. Reed, “Noninvasive measurement of carbon monoxide
levels in ed patients with headache,” Journal of Medical Toxicology,
vol. 2, no. 3, pp. 89–92, 2006.
[43] P. J. Goadsby, “To scan or not to scan in headache: Some patients with
primary headaches may need imaging,” BMJ: British Medical Journal,
vol. 329, no. 7464, p. 469, 2004.
[44] B. M. Frishberg, “The utility of neuroimaging in the evaluation of
headache in patients with normal neurologic examinations,” Neurology,
vol. 44, no. 7, pp. 1191–1191, 1994.
[45] P. Cuijpers et al., “Prevention: an achievable goal in personalized
medicine.” Dialogues in Clinical Neuroscience, vol. 11, no. 4, pp. 447–
454, 2009.
[46] L. Hood and S. H. Friend, “Predictive, personalized, preventive, partici-
patory (p4) cancer medicine,” Nature Reviews Clinical Oncology, vol. 8,
no. 3, pp. 184–187, 2011.
[47] W.-L. Liao and F.-J. Tsai, “Personalized medicine: a paradigm shift in
healthcare,” BioMedicine, vol. 3, no. 2, pp. 66–72, 2013.
[48] R. Ottman and R. B. Lipton, “Comorbidity of migraine and epilepsy,”
Neurology, vol. 44, no. 11, pp. 2105–2105, 1994.
[49] W. R. Gowers, “Clinical lectures on the borderland of epilepsy.
iii.migraine,” British medical journal, vol. 2, no. 2397, p. 1617, 1906.
[50] J. Sander and S. Shorvon, “Epidemiology of the epilepsies,” Journal of
Neurology Neurosurgery and Psychiatry, vol. 61, no. 5, pp. 433–443,
1996.
[51] E. Trinka, H. Cock, D. Hesdorffer, A. O. Rossetti, I. E. Scheffer, S. Shin-
nar, S. Shorvon, and D. H. Lowenstein, “A definition and classification
of status epilepticus–report of the ilae task force on classification of
status epilepticus,” Epilepsia, vol. 56, no. 10, pp. 1515–1523, 2015.
[52] L. M. DeAngelis, “Brain tumors,” New England Journal of Medicine,
vol. 344, no. 2, pp. 114–123, 2001.
[53] A. L. Goldberger, L. A. Amaral, L. Glass, J. M. Hausdorff, P. C. Ivanov,
R. G. Mark, J. E. Mietus, G. B. Moody, C.-K. Peng, and H. E. Stanley,
“Physiobank, physiotoolkit, and physionet components of a new research
resource for complex physiologic signals,” Circulation, vol. 101, no. 23,
pp. e215–e220, 2000.
[54] G. B. Moody, R. G. Mark, and A. L. Goldberger, “Physionet: a web-
based resource for the study of physiologic signals,” IEEE Eng Med
Biol Mag, vol. 20, no. 3, pp. 70–75, 2001.
[55] L. Van der Maaten and G. Hinton, “Visualizing data using t-sne,” Journal
of Machine Learning Research, vol. 9, pp. 2579–2605, 2008.
[56] K. Hornik, M. Stinchcombe, and H. White, “Multilayer feedforward
networks are universal approximators,” Neural networks, vol. 2, no. 5,
pp. 359–366, 1989.
[57] H. Zhang, B. Flynn, A. T. Erdogan, and T. Arslan, “Microwave imaging
for brain tumour detection using an uwb vivaldi antenna array,” in
Antennas and Propagation Conference (LAPC), 2012 Loughborough.
IEEE, 2012, pp. 1–4.
[58] M. Aliroteh, G. Scott, and A. Arbabian, “Frequency-modulated
magneto-acoustic detection and imaging,” Electronics letters, vol. 50,
no. 11, pp. 790–792, 2014.
[59] T. Holscher, “Prehospital use of portable ultrasound for stroke diagnosis
and treatment initiation,” Air Rescue, vol. 5, no. 2, pp. 64–67, 2012.
[60] G. Strangman, D. A. Boas, and J. P. Sutton, “Non-invasive neuroimaging
using near-infrared light,” Biological psychiatry, vol. 52, no. 7, pp. 679–
693, 2002.
[61] Y. LeCun, Y. Bengio, and G. Hinton, “Deep learning,” Nature, vol. 521,
no. 7553, pp. 436–444, 2015.
[62] S. Min, B. Lee, and S. Yoon, “Deep learning in
bioinformatics,” CoRR, vol. abs/1603.06430, 2016. [Online]. Available:
http://arxiv.org/abs/1603.06430
